Gene | ER+ n | ER- n | ORa ER-tumor | Combinedb | PR+ n | PR- n | ORa PR-tumor | Combinedb |
---|---|---|---|---|---|---|---|---|
UGT1A1 | Â | Â | Â | Â | Â | Â | Â | Â |
   (TA)6/(TA)6 | 53 | 21 | 1.0 (ref) | 1.0 (ref) | 57 | 17 | 1.0 (ref) | 1.0 (ref)e |
   (TA)6/(TA)7 | 55 | 16 | 0.6 (0.2–1.3) |  | 55 | 16 | 1.1 (0.5–2.6) |  |
   (TA)7/(TA)7 | 10 | 0 | 0.0 (0.0–0.5)* | 0.5 (0.2–1.1)d | 9 | 1 | 0.3 (0.02–2.6) | 0.2 (0.02–2.4) |
UGT2B4 | Â | Â | Â | Â | Â | Â | Â | Â |
   Asp/Asp | 78 | 21 | 1.0 (ref) | 1.0 (ref) | 81 | 18 | 1.0 (ref) |  |
   Asp/Glu | 30 | 13 | 1.5 (0.6–3.6) |  | 30 | 13 | 2.2 (0.9–5.4) |  |
   Glu/Glu | 10 | 3 | 1.3 (0.3–5.9) | 1.5 (0.6–3.3)d | 10 | 3 | 0.9 (0.2–4.5) |  |
UGT2B7 | Â | Â | Â | Â | Â | Â | Â | Â |
   His/His | 31 | 9 | 1.0 (ref) |  | 33 | 7 | 1.0 (ref) |  |
   His/Tyr | 58 | 12 | 0.6 (0.2–1.7) |  | 52 | 18 | 1.5 (0.5–4.5) |  |
   Tyr/Tyr | 29 | 16 | 1.8 (0.6–5.2) |  | 36 | 9 | 1.4 (0.4–4.5) |  |
UGT2B15 | Â | Â | Â | Â | Â | Â | Â | Â |
   Asp/Asp | 20 | 10 | 1.0 (ref) | 1.0 (ref) | 25 | 5 | 1.0 (ref) |  |
   Asp/Tyr | 61 | 19 | 0.5 (0.2–1.4) |  | 59 | 21 | 1.3 (0.4–4.1) |  |
   Tyr/Tyr | 37 | 8 | 0.4 (0.1–1.2) | 0.5 (0.2–1.2)d | 37 | 8 | 0.6 (0.2–2.4) |  |
SULT1A1 | Â | Â | Â | Â | Â | Â | Â | Â |
   Arg/Arg | 49 | 19 | 1.0 (ref) | 1.0 (ref) | 52 | 16 | 1.0 (ref) | 1.0 (ref) |
   Arg/His | 50 | 13 | 0.6 (0.2–1.3) |  | 50 | 13 | 0.9 (0.4–2.2) |  |
   His/His | 19 | 5 | 0.6 (0.2–1.9) | 0.6 (0.3–1.2)d | 19 | 5 | 0.8 (0.2–2.6) | 0.9 (0.4–2.0)d |